These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 31382960)

  • 41. What Difference Does It Make? A Comparison of Health State Preferences Elicited From the General Population and From People With Multiple Sclerosis.
    Goodwin E; Green C; Hawton A
    Value Health; 2020 Feb; 23(2):242-250. PubMed ID: 32113630
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mapping the schizophrenia quality of life scale to EQ-5D, HUI3 and SF-6D utility scores in patients with schizophrenia.
    Seow LSE; Lau JH; Abdin E; Verma SK; Tan KB; Subramaniam M
    Expert Rev Pharmacoecon Outcomes Res; 2023; 23(7):813-821. PubMed ID: 37216213
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparing and transforming PROMIS utility values to the EQ-5D.
    Hartman JD; Craig BM
    Qual Life Res; 2018 Mar; 27(3):725-733. PubMed ID: 29264776
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Do generic utility measures capture what is important to the quality of life of people with multiple sclerosis?
    Kuspinar A; Mayo NE
    Health Qual Life Outcomes; 2013 Apr; 11():71. PubMed ID: 23618072
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D.
    Shiroiwa T; Fukuda T; Ikeda S; Igarashi A; Noto S; Saito S; Shimozuma K
    Qual Life Res; 2016 Mar; 25(3):707-19. PubMed ID: 26303761
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mapping analyses to estimate EQ-5D utilities and responses based on Oxford Knee Score.
    Dakin H; Gray A; Murray D
    Qual Life Res; 2013 Apr; 22(3):683-94. PubMed ID: 22555470
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mapping QLQ-C30, HAQ, and MSIS-29 on EQ-5D.
    Versteegh MM; Leunis A; Luime JJ; Boggild M; Uyl-de Groot CA; Stolk EA
    Med Decis Making; 2012; 32(4):554-68. PubMed ID: 22114301
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of mapped EQ-5D utilities on cost-effectiveness analysis: in the case of dialysis treatments.
    Yang F; Devlin N; Luo N
    Eur J Health Econ; 2019 Feb; 20(1):99-105. PubMed ID: 29948432
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mapping utility scores from a disease-specific quality-of-life measure in bariatric surgery patients.
    Sauerland S; Weiner S; Dolezalova K; Angrisani L; Noguera CM; García-Caballero M; Rupprecht F; Immenroth M
    Value Health; 2009; 12(2):364-70. PubMed ID: 20667063
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population.
    Petrou S; Hockley C
    Health Econ; 2005 Nov; 14(11):1169-89. PubMed ID: 15942981
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Estimating EQ-5D values from the Neck Disability Index and numeric rating scales for neck and arm pain.
    Carreon LY; Bratcher KR; Das N; Nienhuis JB; Glassman SD
    J Neurosurg Spine; 2014 Sep; 21(3):394-9. PubMed ID: 24905392
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quality of Life and General Health After Elective Surgery for Cervical Spine Pathologies: Determining a Valid and Responsive Metric of Health State Utility.
    Chotai S; Parker SL; Sivaganesan A; Godil SS; McGirt MJ; Devin CJ
    Neurosurgery; 2015 Oct; 77(4):553-60; discussion 560. PubMed ID: 26191977
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessing outcomes for cost-utility analysis in mental health interventions: mapping mental health specific outcome measure GHQ-12 onto EQ-5D-3L.
    Lindkvist M; Feldman I
    Health Qual Life Outcomes; 2016 Sep; 14(1):134. PubMed ID: 27644119
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of the EuroQol and short form 6D in Singapore multiethnic Asian knee osteoarthritis patients scheduled for total knee replacement.
    Xie F; Li SC; Luo N; Lo NN; Yeo SJ; Yang KY; Fong KY; Thumboo J
    Arthritis Rheum; 2007 Aug; 57(6):1043-9. PubMed ID: 17665466
    [TBL] [Abstract][Full Text] [Related]  

  • 55. EQ-5D-5L and SF-6D health utility index scores in patients with myasthenia gravis.
    Barnett C; Bril V; Bayoumi AM
    Eur J Neurol; 2019 Mar; 26(3):452-459. PubMed ID: 30315714
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Modeled cost-effectiveness of transforaminal lumbar interbody fusion compared with posterolateral fusion for spondylolisthesis using N(2)QOD data.
    Carreon LY; Glassman SD; Ghogawala Z; Mummaneni PV; McGirt MJ; Asher AL
    J Neurosurg Spine; 2016 Jun; 24(6):916-21. PubMed ID: 26895529
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multiple sclerosis health-related quality of life utility values from the UK MS register.
    Heather A; Goodwin E; Green C; Morrish N; Ukoumunne OC; Middleton RM; Hawton A
    Mult Scler J Exp Transl Clin; 2023; 9(2):20552173231178441. PubMed ID: 37324245
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mapping between headache specific and generic preference-based health-related quality of life measures.
    Khan K; Mistry H; Matharu M; Norman C; Petrou S; Stewart K; Underwood M; Achana F
    BMC Med Res Methodol; 2022 Oct; 22(1):277. PubMed ID: 36289468
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mapping chronic liver disease questionnaire scores onto SF-6D utility values in patients with primary sclerosing cholangitis.
    Kalaitzakis E; Benito de Valle M; Rahman M; Lindkvist B; Björnsson E; Chapman R; Kontodimopoulos N
    Qual Life Res; 2016 Apr; 25(4):947-57. PubMed ID: 26471264
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Using existing data to identify candidate items for a health state classification system in multiple sclerosis.
    Kuspinar A; Finch L; Pickard S; Mayo NE
    Qual Life Res; 2014 Jun; 23(5):1445-57. PubMed ID: 24338161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.